SequelSEC

Lucid Diagnostics Inc. LUCD

Surgical & Medical Instruments & Apparatus · CIK 0001799011 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2026-06-30
Operating income
-$50.68M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$82.70MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$0.47Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue17.6×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity7.6×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Gross margin-41.7%3th
Operating margin-1054.8%8th
Net margin-1232.7%8th
FCF margin-992.0%10th
R&D / revenue120.7%80th
Current ratio1.31x21th
Revenue YoY growth8.3%36th
CapEx / revenue4.2%56th

Lucid Diagnostics Inc. (LUCD) reported net income of -$52.26M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Lucid Diagnostics Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Lucid Diagnostics Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
RevenueUnavailable
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$50.68M
Net income-$52.26M
Research & development$5.39M
Weighted-average diluted sharesUnavailable
Pretax income-$52.26M
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$43.69M
General & administrative$23.28M
Selling & marketing$20.41M

Balance

Lucid Diagnostics Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalentsUnavailable
Total assets$38.95M
Current assets$36.62M
Total liabilities$28.02M
Current liabilities$27.52M
Total equity incl. NCI$10.93M
Temporary (mezzanine) equityUnavailable
Inventory$484.00K
Accounts receivable$1.09M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$667.00K

Cash flow

Lucid Diagnostics Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$46.87M
Capital expendituresUnavailable
Investing cash flow-$315.00K
Financing cash flow$49.46M
Net change in cash$2.28M
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$875.00K

Derived

Lucid Diagnostics Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross marginUnavailable
Operating marginUnavailable
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio1.33x
Revenue YoY growthUnavailable
Net marginUnavailable
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open LUCD in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-25View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-12View SEC filing
10-Q · Filed 2025-05-13View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.